Needham & Company Reiterates Buy on Intel (INTC) Following 3Q Earnings Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
FIDO Alliance Appoints American Express, Infineon, and VASCO to Board of Directors
October 14, 2015 8:00 AM EDTMOUNTAIN VIEW, CA -- (Marketwired) -- 10/14/15 -- The FIDO (Fast IDentity Online) Alliance (https://www.fidoalliance.org/), an industry consortium launched in 2013 to revolutionize online security with open standards for simpler, stronger authentication, today announced that American... More
FIDO Alliance Opens Worldwide Cooperation & Liaison Program - Welcomes Associations to Partner on FIDO Standards for Universal Strong Authentication
October 13, 2015 8:02 AM EDTMOUNTAIN VIEW, CA -- (Marketwired) -- 10/13/15 -- The FIDO (Fast IDentity Online) Alliance (https://www.fidoalliance.org/), an industry consortium launched in 2013 to revolutionize online security with open standards for simpler, stronger authentication, today introduced the FIDO Cooperation & Liaison Program, inviting associations worldwide to... More
Intec Pharma Announces Topline Results of a Food Effect, Pharmacokinetic Study of AP-CDLD 50/500mg for the Treatment of Parkinson's Disease Symptoms
October 12, 2015 9:38 PM EDTJERUSALEM, ISRAEL -- (Marketwired) -- 10/12/15 -- Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: INTC), a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology, today announced results of the food effect study of the Phase 3 formulation of its leading product candidate, Accordion Pill Carbidopa/Levodopa, or AP-CDLD. The results demonstrated that plasma concentrations of carbidopa and levodopa were similar, with no statistically significant differences in all PK parameters... More
